01 Growing Adoption of AI-Assisted and Single-Use Endoscopy Systems The endoscopes market is shifting toward high-definition imaging, AI-assisted detection, and disposable devices for select procedures. AI-supported software can highlight suspicious lesions during colonoscopy, helping clinicians identify abnormalities that may otherwise be difficult to notice. Advanced imaging methods, including narrow-band and fluorescence imaging, are also improving tissue assessment without immediate surgery. Meanwhile, single-use bronchoscopes, ureteroscopes, and duodenoscopes are gaining attention because they arrive sterile and avoid complex reprocessing. Reusable systems remain important where procedure volumes support their cost. Hospitals are therefore comparing image quality, infection risk, environmental impact, workflow efficiency, and total procedure cost before choosing between reusable and disposable technologies. In April 2025, International gastroenterology guidance expanded discussion of computer-aided detection and diagnosis, supporting controlled adoption of AI during gastrointestinal endoscopy.
01 Rising Cancer Burden and Minimally Invasive Procedures Drive Demand The growing burden of gastrointestinal, respiratory, urinary, and gynecological diseases is increasing demand for diagnostic and therapeutic endoscopy. These instruments allow physicians to examine internal organs, collect biopsies, remove polyps, stop bleeding, and perform selected treatments through small openings. This can reduce hospital stays, recovery time, and surgical trauma compared with open procedures. Ageing populations and wider screening programs are also increasing colonoscopy and upper gastrointestinal examination volumes. Better imaging quality supports earlier identification of precancerous changes and other abnormalities. Demand is further strengthened by the expansion of ambulatory surgical centers, specialist clinics, and hospital endoscopy units in both developed and emerging healthcare systems.
01 High Equipment and Reprocessing Costs Restrict Wider Adoption Advanced endoscopy systems require substantial spending on processors, light sources, monitors, scopes, accessories, repair contracts, and staff training. Reusable instruments create additional costs for cleaning equipment, disinfectants, drying cabinets, water-quality control, documentation, and microbiological monitoring. Complex devices can also require expensive repairs when insertion tubes, cameras, or internal channels are damaged. Smaller hospitals may delay upgrades because procedure volumes are insufficient to justify premium systems. Reimbursement differences across countries further affect purchasing decisions. These financial pressures limit access in lower-income regions and encourage healthcare providers to extend the service life of existing equipment.
01 Screening Expansion and Portable Endoscopy Create Growth Potential Expanding cancer screening and diagnostic access provides a major opportunity for endoscope manufacturers and healthcare providers. Portable and compact systems can support emergency rooms, intensive care units, outpatient clinics, and hospitals that lack permanent endoscopy suites. Single-use devices may be valuable in urgent procedures, infection-sensitive settings, and facilities with limited reprocessing capacity. Emerging economies offer long-term potential as governments invest in hospitals and minimally invasive care. Opportunities also exist in robotic endoscopy, capsule imaging, fluorescence-guided procedures, and smaller instruments designed for pediatric, pulmonary, urological, and ear, nose, and throat applications.
01 Infection Prevention and Reliable AI Performance Remain Critical Preventing infection transmission remains a major challenge because reusable endoscopes contain narrow channels and complex components that can retain biological material. Effective cleaning requires trained staff, validated equipment, correct disinfectant exposure, thorough drying, secure storage, and complete tracking between procedures. Failure at any stage can leave a patient-ready scope contaminated. Single-use alternatives reduce this concern but create more plastic and electronic waste. AI-supported systems present additional challenges involving false alerts, missed lesions, workflow distraction, and uneven performance across patient groups. Hospitals must also manage cybersecurity, software updates, and device interoperability. Maintaining clinical accuracy while controlling costs, waste, infection risk, and staff workload remains difficult.
In September 2025, Olympus announced the U.S. launch of its VISERA S imaging platform, designed for ENT and urological applications. This platform provides advanced diagnostic imaging capabilities across various patient settings.
In July 2025, PENTAX Medical and ASP launched the sterilizable DEC duodenoscope in the U.S. This reusable duodenoscope features a 68-minute sterilization process, allowing for prevention of infection and aligning with environmental goals.
In July 2025, Fujifilm launched the ELUXEO® 8000 Endoscopy System and the 800 Series ELUXEO® Endoscopes at the RCST 2025 conference. These systems offer 4K Ultra HD imaging and a new ACI mode, enhancing precision and treatment outcomes in endoscopic procedures.
In February 2025, Micro-Tech completed the acquisition of a 51% stake in Creo Medical S.L.U. (CME), a subsidiary of Creo Medical Group plc. This acquisition directly impacts the endoscopes market by expanding Micro-Tech’s portfolio of advanced endoscopic devices and technologies, strengthening its position in minimally invasive procedures, and increasing its global footprint in the competitive endoscopy sector.